ProBioGen AG

ProBioGen AG is a leading biotechnology research company, providing intelligent biopharmaceutical solutions to meet the evolving needs of the industry. With 30 years of experience, ProBioGen AG excels as a contract development and manufacturing organization (CDMO), offering cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. The company supports clients in biotech and pharma with proprietary innovative technologies designed for optimized biopharmaceutical manufacturing and analysis.

Operating from its headquarters at Herbert-Bayer-Straße 8, Berlin, 13086, DE, and additional locations at Goethestr. 54, Berlin, 13086, DE, and Prenzlauer Promenade 28, Berlin, 13089, DE, ProBioGen AG is committed to innovation and excellence. The company provides process development services and manufacturing technologies for viral vaccines. ProBioGen AG’s facility includes a 1000 L single-use bioreactor capacity, with plans for a second one to accommodate growing client demand.

ProBioGen AG covers the entire drug development value chain end-to-end, leveraging innovative scientific excellence and a robust intellectual property base. As a trusted partner in biopharmaceutical advancements, ProBioGen AG is dedicated to driving progress and delivering top-tier solutions. We invite the manager of ProBioGen AG to create a customized and exclusive company showcase and product listing on our platform to further highlight their offerings and expertise.